Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 3 March 1972:
Vol. 175. no. 4025, pp. 949 - 955
DOI: 10.1126/science.175.4025.949
Prev | Table of Contents | Next

Articles

Gene Therapy for Human Genetic Disease?

Theodore Friedmann 1 and Richard Roblin 2

1 Department of Pediatrics, University of California, San Diego, P.O. Box 109, La Jolla 92037
2 Infectious Disease Unit, Massachusetts General Hospital, Boston 02114

In our view, gene therapy may ameliorate some human genetic diseases in the future. For this reason, we believe that research directed at the development of techniques for gene therapy should continue. For the foreseeable future, however, we oppose any further attempts at gene therapy in human patients because (i) our understanding of such basic processes as gene regulation and genetic recombination in human cells is inadequate; (ii) our understanding of the details of the relation between the molecular defect and the disease state is rudimentary for essentially all genetic diseases; and (iii) we have no information on the short-range and long-term side effects of gene therapy. We therefore propose that a sustained effort be made to formulate a complete set of ethicoscientific criteria to guide the development and clinical application of gene therapy techniques. Such an endeavor could go a long way toward ensuring that gene therapy is used in humans only in those instances where it will prove beneficial, and toward preventing its misuse through premature application.

Two recent papers have provided new demonstrations of directed genetic modification of mammalian cells. Munyon et al. (44) restored the ability to synthesize the enzyme thymidine kinase to thymidine kinase-deficient mouse cells by infection with ultraviolet-irradiated herpes simplex virus. In their experiments the DNA from herpes simplex virus, which contains a gene coding for thymidine kinase, may have formed a hereditable association with the mouse cells. Merril et al. (45) reported that treatment of fibroblasts from patients with galactosemia with exogenous DNA caused increased activity of a missing enzyme, agr-D-galactose-l-phosphate uridyltransferase. They also provided some evidence that the change persisted after subculturing the treated cells. If this latter report can be confirmed, the feasibility of directed genetic modification of human cells would be clearly demonstrated, considerably enhancing the technical prospects for gene therapy.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Gene Therapy Fulfilling Its Promise.
D. B. Kohn and F. Candotti (2009)
N. Engl. J. Med. 360, 518-521
   Full Text »    PDF »
Interfering RNA-mediated purine analog resistance for in vitro and in vivo cell selection.
C. C. Porter and J. DeGregori (2008)
Blood 112, 4466-4474
   Abstract »    Full Text »    PDF »
Development of gene therapy for blood disorders.
A. W. Nienhuis (2008)
Blood 111, 4431-4444
   Abstract »    Full Text »    PDF »
Gene therapy in clinical medicine.
S M Selkirk (2004)
Postgrad. Med. J. 80, 560-570
   Abstract »    Full Text »    PDF »
Gene Transfer to the Nervous System: Prospects for Novel Treatments Directed at Diseases of the Aging Nervous System.
M. Mata, J. C. Glorioso, and D. J. Fink (2003)
J. Gerontol. A Biol. Sci. Med. Sci. 58, M1111-1118
   Abstract »    Full Text »    PDF »
Gene therapy made difficult.
G J CLESHAM (1998)
Heart 80, 313-314
   Full Text »
Feline Mucopolysaccharidosis Type VI. CHARACTERIZATION OF RECOMBINANT N-ACETYLGALACTOSAMINE 4-SULFATASE AND IDENTIFICATION OF A MUTATION CAUSING THE DISEASE.
G. Yogalingam, T. Litjens, J. Bielicki, A. C. Crawley, V. Muller, D. S. Anson, and J. J. Hopwood (1996)
J. Biol. Chem. 271, 27259-27265
   Abstract »    Full Text »    PDF »
Progress toward human gene therapy.
T Friedmann (1989)
Science 244, 1275-1281
   Abstract »    PDF »
The Molecular Genetic Revolution: Its Impact on Clinical Neurology.
C. S. Payne and A. D. Roses (1988)
Arch Neurol 45, 1366-1376
   Abstract »    PDF »
Prospects for human gene therapy.
W. Anderson (1984)
Science 226, 401-409
   Abstract »    PDF »
Brave New World?.
A. G. Motulsky (1974)
Science 185, 653-663
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)